Leukemia, Prolymphocytic - 55 Studies Found
Completed |
: Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) : Leukemia, Lymphocytic, Chronic : 2007-04-20 : Drug: alvocidib 1st dose: 30 mg/m2 as a 30-minute intraven |
Withdrawn |
: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation :
: |
Active, not recruiting |
: Ofatumumab and Dinaciclib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia :
: |
Active, not recruiting |
: ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia :
|
Completed |
: Compassionate Use of Campath-1H in Treating Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia : Leukemia : 2001-07-11 : Biological: alemtuzumab |
Completed |
: Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) :
: 2005-08-02 :
|
Active, not recruiting |
: Acalabrutinib in Combination With Obinutuzumab in Relapsed/Refractory or Untreated CLL/SLL/PLL :
|
Completed |
: AZD6738 First Time in Patient Multiple Ascending Dose Study :
|
Completed |
: Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias :
: 2007-05-11 :
|